Skip to main content
SCNX logo

Scienture Holdings, Inc.

SCNXNASDAQHealthcarePharmaceutical Retailers

$2.93Today:- (-)1Y +6.54%

As of Oct 26, 2026 close

Market cap
$116.07M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.24$12.02
Volume (live)
-
Avg. volume (3M)
299.96K

Scienture Holdings (SCNX) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Scienture Holdings used $13.38M of cash in operating activities. Free cash flow was −$13.38M.

Scienture Holdings Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Scienture Holdings, Inc. (SCNX) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-43.51-18.24-8.48-2.40-5.32-2.54-0.280.010.29
Depreciation & Amortization0.490.051.050.190.140.100.090.000.00
Stock Based Compensation2.070.030.260.210.391.360.000.000.00
Change in Working Capital-3.07-2.605.510.141.08-3.60-0.670.08-0.50
Change in Accounts Receivable-0.80-2.93-0.55-0.510.30-0.02-0.370.00-0.02
Change in Inventory-0.210.004.23-0.050.83-2.420.020.000.00
Change in Accounts Payable-1.570.451.610.200.22-0.03-0.150.10-0.10
Change in Other Working Capital-0.485.510.220.83-0.24-1.12-0.17-0.01-0.38
Other Operating Activities30.635.51-0.561.421.142.461.000.180.39
Net Cash from Operating Activities-13.38-14.27-2.23-3.35-2.57-2.210.140.270.17
Investing Activities
Capital Expenditures0.00-0.010.00-0.45-0.02-0.04-0.08-0.020.00
Acquisitions0.000.13-0.340.000.000.00-0.25-0.250.00
Purchases of Investments0.00-2.500.000.000.000.000.000.000.00
Other Investing Activities0.0029.930.07-0.430.000.000.000.000.00
Net Cash from Investing Activities0.0027.55-0.28-0.43-0.02-0.04-0.33-0.270.00
Financing Activities
Debt Repayment-6.163.100.25-0.72-0.230.00-0.26-0.12-0.25
Common Stock Issued26.290.030.520.130.025.992.460.800.25
Dividends Paid0.00-14.860.000.000.000.000.000.000.00
Other Financing Activities-0.40-1.250.640.830.02-0.690.000.000.00
Net Cash from Financing Activities19.73-12.981.410.85-0.215.302.190.680.00
Summary
Effect of Forex Changes on Cash0.000.000.000.000.000.000.000.000.00
Net Change in Cash6.350.31-1.09-2.50-2.803.052.000.690.17
Cash at Beginning of Period0.310.001.093.125.922.870.870.180.01
Cash at End of Period6.660.310.001.093.125.922.870.870.18
Free Cash Flow-13.38-14.28-2.23-3.35-2.59-2.250.060.260.17
Supplemental Disclosures
Interest Paid--0.73------

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Scienture Holdings Cash Flow

What is Scienture Holdings's free cash flow?

Scienture Holdings had negative free cash flow of $13.38M in fiscal 2025 (fiscal year ended Dec 31, 2025).

Does Scienture Holdings pay dividends or buy back shares?

Scienture Holdings's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition